HOME
HK STOCK
ALL
Announcement
IPOs
Research
Market
Company
CHINA STOCK
ALL
Announcement
IPOs
Research
Market
Company
US STOCK
ALL
Financial Report
New Share
Market
Research
Company
RECOMMENDATIONS
ALL
World News
Hong Kong & MaCao
China News
General News
HK STOCK
ALL
Announcement
IPOs
Research
Market
Company
CHINA STOCK
ALL
Announcement
IPOs
Research
Market
Company
US STOCK
ALL
Financial Report
New Share
Market
Research
Company
RECOMMENDATIONS
ALL
World News
Hong Kong & MaCao
China News
General News
HOME
HK STOCK
ALL
Announcement
IPOs
Research
Market
Company
CHINA STOCK
ALL
Announcement
IPOs
Research
Market
Company
US STOCK
ALL
Financial Report
New Share
Market
Research
Company
RECOMMENDATIONS
ALL
World News
Hong Kong & MaCao
China News
General News
Search for topics & keywords
Search
SITC (01308) will distribute a final dividend of HK$1.4 per share on May 22.
10/03/2025
GMT Eight
SITC (01308) announces that the company will distribute a final dividend of HK$1.4 per share on May 22, 2025.
SITC (01308) announced its annual performance, with a net profit attributable to shareholders of $1.028 billion, representing a year-on-year growth of 93.51%.
Key clinical data has met research expectations, TYK MEDICINES-B (02410) shows high value potential.
RECOMMEND
GAUSH MEDITECH (02407) wholly-owned subsidiary achieved a key milestone in MDR; and the self-developed hydrophilic acrylic intraocular lens (IOL) product portfolio obtained MDR CE certification.
6 min ago
SKB BIO-B(06990):The core product sac-TMT has been approved by the National Medical Products Administration for a second indication, for the treatment of EGFR-mutated non-small cell lung cancer.
6 min ago
Zhejiang Xianju Pharmaceutical (002332.SZ) has obtained the domestic production drug registration certificate for ethinylestradiol tablets.
6 min ago
©️2013 - 2025 GMT EIGHT Holdings. All Rights Reserved.
Contact: contact@gmteight.com